Paragon Care Limited Share Price

Equities

PGC

AU000000PGC4

Medical Equipment, Supplies & Distribution

Market Closed - Australian S.E. 07:10:44 26/04/2024 BST 5-day change 1st Jan Change
0.34 AUD 0.00% Intraday chart for Paragon Care Limited +4.62% +51.11%

Financials

Sales 2024 * 325M 212M 16.99B Sales 2025 * 348M 228M 18.22B Capitalization 227M 148M 11.87B
Net income 2024 * 10M 6.53M 523M Net income 2025 * 14M 9.14M 732M EV / Sales 2024 * 0.95 x
Net Debt 2024 * 82.4M 53.82M 4.31B Net Debt 2025 * 69.8M 45.59M 3.65B EV / Sales 2025 * 0.85 x
P/E ratio 2024 *
22.7 x
P/E ratio 2025 *
16.2 x
Employees 400
Yield 2024 *
-
Yield 2025 *
3.82%
Free-Float 61.21%
More Fundamentals * Assessed data
Dynamic Chart
1 week+4.62%
Current month+9.68%
1 month+21.43%
3 months+61.90%
6 months+94.29%
Current year+51.11%
More quotes
1 week
0.32
Extreme 0.32
0.34
1 month
0.29
Extreme 0.292
0.34
Current year
0.20
Extreme 0.2
0.34
1 year
0.15
Extreme 0.15
0.34
3 years
0.15
Extreme 0.15
0.49
5 years
0.10
Extreme 0.095
0.52
10 years
0.10
Extreme 0.095
0.97
More quotes
Managers TitleAgeSince
Chief Executive Officer - 15/02/22
Corporate Secretary - 14/08/22
Corporate Secretary 51 28/06/18
Members of the board TitleAgeSince
Chief Executive Officer - 15/02/22
Chairman 70 20/12/05
Director/Board Member - 02/06/16
More insiders
Date Price Change Volume
26/04/24 0.34 0.00% 156,613
24/04/24 0.34 0.00% 1,847,245
23/04/24 0.34 0.00% 756,324
22/04/24 0.34 +4.62% 1,126,720
19/04/24 0.325 0.00% 191,902

Delayed Quote Australian S.E., April 26, 2024 at 07:10 am

More quotes
Paragon Care Limited is an Australia-based company. It is engaged in the supply of durable medical equipment, medical devices and consumable medical products and maintenance of technical medical equipment to the health, aged care and veterinary markets throughout Australia. Its segments include Diagnostic and Scientific, Devices, Capital and Consumables, and Service and Technology. Diagnostic and Scientific segment incorporates blood bank diagnostics manufacturer, clinical pathology diagnostics distribution and scientific and research and development (R&D) laboratory equipment distribution. Devices Segment incorporates ophthalmology and optometry, orthopedics, pain management, infection prevention and ortho biologics. Capital and Consumables segment includes medical, surgical and veterinary services. Service and Technology segment includes offering from biomedical devices to high end capital equipment, service support and technology management and service partnership with brands.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.34 AUD
Average target price
0.31 AUD
Spread / Average Target
-8.82%
Consensus